Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories weighted-Average Diluted Shares Outstanding (Millions) (M)
Postgres DB financial_values
Latest, Q2 2026
1,743
Period ended Jun 30, 2026
Change on a year earlier
-0.4%
1,751 in Q2 2025
History
55 quarters
Since Q2 2008
Sources
52
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-Average Diluted Shares Outstanding (Millions) (M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,743 | -0.4% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,747 | 0.0% | Form 10-Q (filed 2026-04-29) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,749 | +0.1% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,751 | 0.0% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,747 | -0.1% | Form 10-Q (filed 2025-04-30) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,748 | 0.0% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,751 | +0.1% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,750 | -0.1% | Form 10-Q (filed 2024-05-02) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,748 | -0.9% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,750 | -0.9% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,752 | -1.3% | Form 10-Q (filed 2023-05-04) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,764 | -1.4% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,766 | -1.6% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,775 | -0.9% | Form 10-Q (filed 2022-05-03) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,789 | +0.1% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,793 | +0.5% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,792 | +0.6% | Form 10-Q (filed 2021-05-05) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,788 | +0.2% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,785 | +0.2% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,781 | +0.2% | Form 10-Q (filed 2020-04-29) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,784 | +0.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,781 | +0.7% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,777 | +0.6% | Form 10-Q (filed 2019-05-01) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,772 | +1.0% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 1,769 | +1.1% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,765 | +1.7% | Form 10-Q (filed 2018-05-02) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,754 | +18.8% | Form 10-Q (filed 2017-11-02) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,749 | +18.1% | Form 10-Q (filed 2017-08-02) ↗ |
| Q1 2017 | Mar 31, 2017 | 1,735 | +17.0% | Form 10-Q (filed 2017-05-03) ↗ |
| Q3 2016 | Sep 30, 2016 | 1,476 | -1.9% | Form 10-Q (filed 2016-11-03) ↗ |
| Q2 2016 | Jun 30, 2016 | 1,481 | -1.6% | Form 10-Q (filed 2016-08-03) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,484 | -2.1% | Form 10-Q (filed 2016-05-04) ↗ |
| Q3 2015 | Sep 30, 2015 | 1,505 | -1.0% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 1,504 | -0.8% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 1,516 | -2.1% | Form 10-Q (filed 2015-05-06) ↗ |
| Q3 2014 | Sep 30, 2014 | 1,520 | -3.0% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 1,517 | -3.8% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,548 | -2.4% | Form 10-Q (filed 2014-05-07) ↗ |
| Q3 2013 | Sep 30, 2013 | 1,567 | -1.7% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,577 | -0.7% | Form 10-Q (filed 2013-08-06) ↗ |
| Q1 2013 | Mar 31, 2013 | 1,586 | -0.2% | Form 10-Q (filed 2013-05-08) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,594 | +1.7% | Form 10-Q (filed 2012-11-07) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,589 | +1.4% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 1,590 | +2.0% | Form 10-Q (filed 2012-05-08) ↗ |
| Q3 2011 | Sep 30, 2011 | 1,568 | +0.9% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 1,566 | +0.9% | Form 10-Q (filed 2011-08-04) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,559 | -0.2% | Form 10-Q (filed 2011-05-06) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,554 | +0.1% | Form 10-Q (filed 2010-11-05) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,552 | +0.1% | Form 10-Q (filed 2010-08-05) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,561 | +0.3% | Form 10-Q (filed 2010-05-04) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,553 | -0.7% | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,551 | -0.2% | Form 10-Q (filed 2009-08-07) ↗ |
| Q1 2009 | Mar 31, 2009 | 1,556 | – | Form 10-Q (filed 2010-05-04) ↗ |
| Q3 2008 | Sep 30, 2008 | 1,564 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2008 | Jun 30, 2008 | 1,553 | – | Form 10-Q (filed 2009-08-07) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Weighted-Average Diluted Shares Outstanding (Millions) (M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-sh-dil
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.